1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS

Authors :: G.T. Everson
B. Bernstein
M. Heckaman
T. Pilot Matias
Fred Poordad
D. Cohen
R. Menon
S. Siggelkow
B. Freilich
Kris V. Kowdley
T. Podsadecki
E.J. Lawitz
Source :: Journal of Hepatology. 56:S549-S550
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Interferon free
Ribavirin
Gastroenterology
Therapy naive
Non responders
chemistry.chemical_compound
Regimen
Hcv genotype 1
chemistry
Internal medicine
medicine
business

Tools